Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease multiple endocrine neoplasia type 1
Comorbidity C0029456|osteoporosis
Sentences 26
PubMedID- 20148745 Although osteoporosis in men is an increasing health problem, studies on osteoporosis in males are still scarce.
PubMedID- 26217383 However, research on osteoporosis in men is still lacking.
PubMedID- 23710562 The ginerisk study was a cross-sectional epidemiological study conducted in 4157 spanish postmenopausal women initially diagnosed with osteoporosis according to who criteria within the last 2 years.
PubMedID- 20721937 (9) plausible explanations for such high rates among men included secondary causes of osteoporosis such as reduced physical activity and diet.
PubMedID- 23150144 This report provides the 2-year data from this study and assesses whether 2cdm provides continued efficacy and safety similar to the 5 mg daily regimen in postmenopausal women with osteoporosis during the second year of treatment.
PubMedID- 25432358 Drugs now approved for treatment of osteoporosis in men include the anti-resorptive bisphosphonates alendronate, residronate and zoledronic acid, the anti-resorptive drug denosumab, the bone-forming agent teriparatide, and (not in the us) strontium ranelate with mild opposite effects on resorption and formation.
PubMedID- 24688907 Food habits related to osteoporosis in women in iran.
PubMedID- 21632675 Conclusion: the prevalence of secondary osteoporosis in men is similar to that in women and it is less frequent than commonly reported.
PubMedID- 22924057 Androgen-deficient osteoporosis in men is treated with testosterone therapy, which is associated with side effects.
PubMedID- 20375885 osteoporosis in men is an important public health problem.
PubMedID- 21113693 osteoporosis in men is finally receiving some attention; it has been realized that men are more likely to die after hip fracture.
PubMedID- 23362466 osteoporosis in men is a heterogeneous disease that has received little attention.
PubMedID- 20056806 Context: osteoporosis in men is becoming an increasingly important public health problem.
PubMedID- 21853294 osteoporosis in men is an overlooked yet increasingly important clinical problem that, historically, has not received the same degree of awareness as with women.
PubMedID- 24613388 The diagnosis of osteoporosis in men is controversial, although most studies demonstrate similar fracture rates for men and women with the same level of hip bone mineral density (bmd).
PubMedID- 20560686 Prevalence of osteoporosis in men in a va rehabilitation center.
PubMedID- 22349078 Postmenopausal osteoporosis in women is characterized by an increase in bone fragility and risk of fracture.
PubMedID- 24554932 osteoporosis in men is less frequent than in women and is more often due to an underlying cause, such as nutritional deficiencies or lifestyle factors, endocrinological or systemic affections, long-term specific therapies.
PubMedID- 23440083 osteoporosis in men is an underrecognized and undertreated condition.
PubMedID- 24396677 The prevalence of osteoporosis in men in their 50s was 4.0%, in their 60s was 7.2%, in their 70s was 15.1%, and in their 80s was 26.7%.
PubMedID- 22079368 Treatment of osteoporosis in women intolerant of oral bisphosphonates.
PubMedID- 20938224 osteoporosis in men is an increasingly important clinical issue.
PubMedID- 24994809 Among men identified with osteoporosis by who criteria, who comprised 2% of the study population, actual observed fracture probabilities during 10 years of follow-up were highest and exceeded frax predicted fracture probabilities.
PubMedID- 21359668 osteoporosis in men is underdiagnosed.
PubMedID- 26010450 Context: the preferred treatment for osteoporosis in men is debated, and pairwise meta-analysis cannot obtain hierarchies of these treatments.
PubMedID- 26331008 osteoporosis in men is a major and neglected public health issue.

Page: 1